Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Hyperbaric Oxygen (HBO) Effects on Blood Count Recovery and Post-Transplant Outcomes Following High-Dose Therapy and Autologous HSPC Transplantation for Multiple Myeloma: A Multicenter Phase II Randomized Clinical Trial

Leyla Shune, Ayman Qasrawi, Gerhard Hildebrandt, Eric J Huselton, Howard Langstein, Dennis Allin, Kaitlyn Burrows, Andrea M Baran, Jane L. Liesveld, Neil Blumberg, Brea Lipe, Andrew G Evans, Derick R Peterson, Omar Aljitawi

Blood (2023) 142 (Supplement 1): 2221.

https://doi.org/10.1182/blood-2023-190079

Published: 2023

Journal Articles

Lisocabtagene Maraleucel as Second-Line Therapy for R/R Large B-Cell Lymphoma in Patients Not Intended for Hematopoietic Stem Cell Transplant: Final Analysis of the Phase 2 PILOT Study

Blood (2023) 142 (Supplement 1): 105.

https://doi.org/10.1182/blood-2023-180952

Published: 2023

Journal Articles

Changes in Killer-Cell Immunoglobulin-like Receptor (KIR) Expression on NK Cells Following DNA Demethylation By Azacitidine in Relapsed and Refractory Lymphomas

Runa Shrestha, MD, Ahmad Al-Attar, MD, John W Hayslip, MD, Lutz T Charles, MD, Emily Dressler, PhD, Jabbour Hossam, MD, Maryam F Zia, MD, Hayder Saeed, MD, Amit Goldberg, MD, Gregory Monohan, MD, Roger Herzig, MD, Roger A Fleischman, MD, PhD, Gerhard Hildebrandt, MD, Shams A Shakil, MD, PhD

Blood (2016) 128 (22): 5296.

https://doi.org/10.1182/blood.V128.22.5296.5296

Published: 2016

Journal Articles

Biomodulatory Metronomic Therapy Shows Remarkable Activity in Chemorefractory Multi-System Langerhans Cell Histiocytosis

Daniel Heudobler, MD, Klaus Rehe, MD PhD, Juergen Foell, MD, Selim Corbacioglu, MD, Gerhard Hildebrandt, MD, Wolfgang Herr, MD, Albrecht Reichle, MD, Martin Vogelhuber, MD

Blood (2016) 128 (22): 4254.

https://doi.org/10.1182/blood.V128.22.4254.4254

Published: 2016

Journal Articles

Is Interim/Mid-Treatment PET (interim PET, i-PET) Scan Predictive of Outcome in Diffuse Large B-Cell Lymphoma?.

Dushyant Verma, MD, FACP, Amol Takalkar, MD, Runhua Shi, MD, PhD, Glenn M. Mills, MD, FACP, Srikanth Paladugu, MD, Diana Veillon, MD, Reinhold Munker, MD, Gerhard Hildebrandt, MD, Binu S. Nair, MD, FACP, Nebu Koshy, MD, FACP

Blood (2012) 120 (21): 2675.

https://doi.org/10.1182/blood.V120.21.2675.2675

Published: 2012

Journal Articles

The Prolyl Hydroxylase Inhibitor Dimethyl Oxalyl Glycine Decreases the Severity of Acute Lung Injury After Allogeneic Hematopoietic Cell Transplantation.

Sabarinath Venniyil Radhakrishnan, MD, Senthilnathan Palaniyandi, PhD, Fridrik Karlsson, PhD, Elisabeth Huber, MD, Gerhard Hildebrandt, MD

Blood (2012) 120 (21): 3006.

https://doi.org/10.1182/blood.V120.21.3006.3006

Published: 2012

Journal Articles

Validation of the Lung Function Score as a Valuable Parameter for the Assessment of Chronic Graft-Versus-Host Disease and Clinical Outcome After Allogeneic Haematopoietic Cell Transplantation.

Diana Ditz, MD, Robert Rabanus, MD, Christian Schulz, MD, PhD, Daniel Wolff, MD, PhD, Reinhard Andreesen, MD, PhD, Ernst Holler, MD, PhD, Gerhard Hildebrandt, MD, PhD

Blood (2009) 114 (22): 2259.

https://doi.org/10.1182/blood.V114.22.2259.2259

Published: 2009

Journal Articles

The lung's friend, the gut's foe

Gerhard Hildebrandt

Blood (2007) 110 (3): 792–793.

https://doi.org/10.1182/blood-2007-05-089110

Published: 2007

Journal Articles

Donor -173 G/C Polymorphism of Macrophage Migration Inhibitory Factor Gene Is Associated with the Development of Chronic Graft Versus Host Disease.

Yayi Chang, MS, Ernst Holler, MD, Heike Bremm, Hildegard T. Greinix, MD, Reinhard Andreesen, MD, Gerhard Hildebrandt, MD

Blood (2006) 108 (11): 2873.

https://doi.org/10.1182/blood.V108.11.2873.2873

Published: 2006

Journal Articles

NOD2/CARD15 Variants of Donor and Recipient as Critical Risk Factors for the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Stem Cell Transplantation.

Gerhard Hildebrandt, MD, Daniel Wolff, MD, Bernd Hertenstein, MD, Hildegard T. Greinix, MD, Gerhard Rogler, MD, Julia Brenmoehl, Cand.phil., Christian Schulz, MD, Anne M. Dickinson, MD, Reinhard Andreesen, MD, Ernst Holler, MD

Blood (2005) 106 (11): 144.

https://doi.org/10.1182/blood.V106.11.144.144

Published: 2005

Journal Articles

Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects

Pavan Reddy, Takanori Teshima, Gerhard Hildebrandt, Debra L. Williams, Chen Liu, Kenneth R. Cooke, James L.M. Ferrara

Blood (2003) 101 (7): 2877–2885.

https://doi.org/10.1182/blood-2002-08-2566

Published: 2003

Journal Articles

Interleukin 18 preserves a perforin-dependent graft-versus-leukemia effect after allogeneic bone marrow transplantation

Pavan Reddy, Takanori Teshima, Gerhard Hildebrandt, Ulrich Duffner, Yoshinobu Maeda, Kenneth R. Cooke, James L. M. Ferrara

Blood (2002) 100 (9): 3429–3431.

https://doi.org/10.1182/blood-2002-04-1252

Published: 2002

NARROW

Hyperbaric Oxygen (HBO) Effects on Blood Count Recovery and Post-Transplant Outcomes Following High-Dose Therapy and Autologous HSPC Transplantation for Multiple Myeloma: A Multicenter Phase II Randomized Clinical Trial

Lisocabtagene Maraleucel as Second-Line Therapy for R/R Large B-Cell Lymphoma in Patients Not Intended for Hematopoietic Stem Cell Transplant: Final Analysis of the Phase 2 PILOT Study

Changes in Killer-Cell Immunoglobulin-like Receptor (KIR) Expression on NK Cells Following DNA Demethylation By Azacitidine in Relapsed and Refractory Lymphomas

Biomodulatory Metronomic Therapy Shows Remarkable Activity in Chemorefractory Multi-System Langerhans Cell Histiocytosis

Is Interim/Mid-Treatment PET (interim PET, i-PET) Scan Predictive of Outcome in Diffuse Large B-Cell Lymphoma?.

The Prolyl Hydroxylase Inhibitor Dimethyl Oxalyl Glycine Decreases the Severity of Acute Lung Injury After Allogeneic Hematopoietic Cell Transplantation.

Validation of the Lung Function Score as a Valuable Parameter for the Assessment of Chronic Graft-Versus-Host Disease and Clinical Outcome After Allogeneic Haematopoietic Cell Transplantation.

The lung's friend, the gut's foe

Donor -173 G/C Polymorphism of Macrophage Migration Inhibitory Factor Gene Is Associated with the Development of Chronic Graft Versus Host Disease.

NOD2/CARD15 Variants of Donor and Recipient as Critical Risk Factors for the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Stem Cell Transplantation.

Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects

Interleukin 18 preserves a perforin-dependent graft-versus-leukemia effect after allogeneic bone marrow transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only